BIOTEC BETAGLUCANS AS

9010 TROMSØ

Finances

Share Ownership

Return on Equity

17,39 %

Current Ratio

2,17

Debt-to-Equity Ratio

Key figures (NOK)	2023	2022	2020	2019
Revenue	23 473 000	90 778 000	49 836 000	35 847 000
Net Income	2 359 000	66 138 000	587 000	−17 075 000
Total Assets	22 608 000	26 288 000	26 104 000	28 375 000
Total Equity	13 569 000	17 210 000	22 072 000	21 485 000

Income (NOK)	2023	2022	2020	2019
Revenue	23 473 000	90 778 000	49 836 000	35 847 000
Expenditure	21 547 000	25 484 000	49 243 000	51 543 000
Operating Profit	1 925 000	65 294 000	448 000	−17 166 000
Financial Income	2 583 000	994 000	141 000	103 000
Financial Costs	2 150 000	150 000	3 000	12 000
Financial Balance	433 000	844 000	138 000	91 000
Earnings Before Tax	2 359 000	66 138 000	587 000	−17 075 000
Tax	0	0	0	0
Net Income	2 359 000	66 138 000	587 000	−17 075 000

Balance (NOK)	2023	2022	2020	2019
Total Fixed Assets	2 965 000	2 172 000	2 702 000	15 428 000
Total Current Assets	19 643 000	24 116 000	23 402 000	12 947 000
Total Assets	22 608 000	26 288 000	26 104 000	28 375 000
Total Retained Equity	12 569 000	16 210 000	−159 965 000	−160 552 000
Total Equity	13 569 000	17 210 000	22 072 000	21 485 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	9 039 000	9 078 000	4 032 000	6 890 000
Total Equity and Debt	22 608 000	26 288 000	26 104 000	28 375 000

Cash flow (NOK)	2023	2022	2020	2019
Sales Income	16 190 000	25 901 000	49 624 000	32 055 000
Other Income	7 283 000	64 877 000	213 000	3 792 000
Revenue	23 473 000	90 778 000	49 836 000	35 847 000
Cost of Goods Sold	4 703 000	8 934 000	20 657 000	16 230 000
Salary Costs	8 911 000	7 905 000	8 172 000	17 225 000
Depreciation	501 000	1 496 000	6 647 000	8 017 000
Impairment	0	0	6 197 000	0
Expenditure	21 547 000	25 484 000	49 243 000	51 543 000
Operating Profit	1 925 000	65 294 000	448 000	−17 166 000
Financial Income	2 583 000	994 000	141 000	103 000
Financial Costs	2 150 000	150 000	3 000	12 000
Financial Balance	433 000	844 000	138 000	91 000
Dividends	6 000 000	0	0	0
Net Income	2 359 000	66 138 000	587 000	−17 075 000

Balance details (NOK)	2023	2022	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	982 000	13 449 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	2 112 000	1 822 000	1 438 000	1 911 000
Fixtures	853 000	350 000	282 000	68 000
Total Tangible Assets	2 965 000	2 172 000	1 720 000	1 978 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	2 965 000	2 172 000	2 702 000	15 428 000
Stock	6 336 000	2 862 000	2 690 000	2 835 000
Total Investments	0	0	0	0
Cash, Bank	2 832 000	19 577 000	19 467 000	335 000
Total Current Assets	19 643 000	24 116 000	23 402 000	12 947 000
Total Assets	22 608 000	26 288 000	26 104 000	28 375 000
Total Equity	13 569 000	17 210 000	22 072 000	21 485 000
Short-Term Group Debt	238 000	5 732 000	0	897 000
Total Long-Term Debt	0	0	0	0
Creditors	599 000	682 000	2 431 000	3 791 000
Unpaid Taxes	65 000	230 000	271 000	516 000
Dividends	6 000 000	0	0	0
Other Current Debt	2 138 000	2 435 000	1 330 000	1 685 000
Total Current Debt	9 039 000	9 078 000	4 032 000	6 890 000
Total Equity and Debt	22 608 000	26 288 000	26 104 000	28 375 000

Financial indicators	2023	2022	2020	2019
Return on Equity	17,39 %	384,3 %	2,66 %	−79,47 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	8,2 %	71,93 %	0,9 %	−47,89 %
Current Ratio	2,17	2,66	5,8	1,88
Quick Ratio	7,27	3,88	17,44	3,19
Equity Ratio	0,6	0,65	0,85	0,76
Gross Profit Margin	79,96 %	90,16 %	58,55 %	54,72 %